Literature DB >> 3493236

Beta-lactamase stability of imipenem.

R Labia, A Morand, M Guionie.   

Abstract

The beta-lactamase stability and interactions of imipenem were analysed in comparison with those of cefazolin, cefuroxime, cefoxitin, cefotaxime, ceftazidime, mezlocillin, piperacillin and penicillin G for a set of representative beta-lactamases. These enzymes included penicillinases such as those obtained from Staphylococcus aureus, Escherichia coli and other Enterobacteriaceae (TEM-1 and similar enzymes) (group A); cephalosporinases produced by Esch. coli (Amp C type), Serratia liquefaciens, Enterobacter cloacae, Pseudomonas aeruginosa (group B); and beta-lactamases produced by Klebsiella spp., Proteus vulgaris and Bacteroides fragilis and with a high hydrolytic activity for the newer cephalosporins (group C). Enzymes of group A were demonstrated to be highly active against penicillins and also against the early cephalosporins; enzymes of group B showed hydrolytic activity for all other tested compounds, including the newer cephalosporins and cephamycins, but not imipenem, whereas enzymes of group C were highly active against the new cephalosporins but not against cephamycins and imipenem. In conclusion, imipenem shows a moderate affinity for all these enzymes but no detectable hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3493236     DOI: 10.1093/jac/18.supplement_e.1

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against gram-positive and gram-negative bacteria.

Authors:  I Odenholt; E Löwdin; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

2.  Influence on Enterobacter cloacae metabolism, cell-surface hydrophobicity and motility of suprainhibitory concentrations of carbapenems.

Authors:  V Majtán; L Majtánová
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

3.  Changing causes of septicaemia in paediatric oncology patients: effect of imipenem use.

Authors:  J W Gray; S J Pedler; A W Craft; J Kernahan; K P Windebank; A D Pearson
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

Review 4.  Acinetobacter baumannii Resistance: A Real Challenge for Clinicians.

Authors:  Rosalino Vázquez-López; Sandra Georgina Solano-Gálvez; Juan José Juárez Vignon-Whaley; Jorge Andrés Abello Vaamonde; Luis Andrés Padró Alonzo; Andrés Rivera Reséndiz; Mauricio Muleiro Álvarez; Eunice Nabil Vega López; Giorgio Franyuti-Kelly; Diego Abelardo Álvarez-Hernández; Valentina Moncaleano Guzmán; Jorge Ernesto Juárez Bañuelos; José Marcos Felix; Juan Antonio González Barrios; Tomás Barrientos Fortes
Journal:  Antibiotics (Basel)       Date:  2020-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.